(Q43776191)

26 November 2017

Fluvoxamine augmentation increases serum mirtazapine concentrations three- to fourfold (English)

1 reference

26 November 2017

1 reference

A K Anttila

1

1 reference

26 November 2017

L Rasanen

series ordinal

2

1 reference

26 November 2017

E V Leinonen

series ordinal

3

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

Annals of Pharmacotherapy

26 November 2017

1 reference

26 November 2017

35

1 reference

26 November 2017

1221-1223

1 reference

26 November 2017

10

1 reference

SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression

26 November 2017

1 reference

Clinical pharmacokinetics of mirtazapine

21 January 2018

1 reference

Nimesulide: some pharmaceutical and pharmacological aspects--an update

21 January 2018

1 reference

Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders

21 January 2018

1 reference

Phenytoin-tizanidine interaction

21 January 2018

1 reference

Human cytochromes and some newer antidepressants: kinetics, metabolism, and drug interactions.

21 January 2018

1 reference

Fluvoxamine but not citalopram increases serum melatonin in healthy subjects-- an indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatonin.

21 January 2018

1 reference

A method for estimating the probability of adverse drug reactions

21 January 2018

1 reference

Pharmacokinetic Interaction of Fluvoxamine and Thioridazine in Schizophrenic Patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1A014

1 reference

26 November 2017

1 reference